Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling(Harvard University), Creighton H. Phelps(National Institute on Aging), David A. Bennett(Rush University Medical Center), Suzanne Craft(Wake Forest University), Christopher C. Rowe(The University of Melbourne), Anne M. Fagan(Washington University in St. Louis), María C. Carrillo(Brigham and Women's Hospital), Yaakov Stern(Columbia University), Jeffrey Kaye(Oregon Health & Science University), Bill Thies(Alzheimer's Association), Eric M. Reiman(Alzheimer's Association), Kristine Yaffe(University of California, San Francisco), Laurel Beckett(Brigham and Women's Hospital), Denise C. Park(The University of Texas at Dallas), Takeshi Iwatsubo(National Center of Neurology and Psychiatry), Eric Siemers(Eli Lilly (United States)), Paul Aisen(University of Southern California), Marcelle Morrison‐Bogorad(National Institute on Aging), Thomas J. Montine(Stanford University), Molly V. Wagster(National Institute on Aging), Clifford R. Jack(Mayo Clinic)
Cited by 7,148
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k